http://orcid.org/0000-0003-3855-0246
About the Authors
- Kameran Lashkari
-
Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Supervision, Validation
* E-mail: kameran_lashkari@meei.harvard.edu
Affiliation Schepens Eye Research Institute, Mass Eye & Ear, Harvard Medical School, Boston, Massachusetts, United States of America
- Gianna Teague
-
Roles Investigation, Project administration
Affiliation Schepens Eye Research Institute, Mass Eye & Ear, Harvard Medical School, Boston, Massachusetts, United States of America
- Hong Chen
-
Roles Formal analysis, Investigation, Methodology
Affiliation Alliance Pharma, Malvern, Pennsylvania, United States of America
- Yong-Qing Lin
-
Roles Formal analysis, Investigation, Methodology
Affiliation Alliance Pharma, Malvern, Pennsylvania, United States of America
- Sanjay Kumar
-
Roles Conceptualization, Formal analysis, Methodology
Affiliation Alternative Discovery & Development, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America
- Megan M. McLaughlin
-
Roles Conceptualization, Formal analysis, Methodology
Affiliation Alternative Discovery & Development, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America
- Francisco J. López
-
Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology
Current address: Allergan plc., Irvine, California, United States of America
Affiliation Alternative Discovery & Development, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America
Competing Interests
Authors SK, MMMcL are and FJL was affiliated with GlaxoSmithKline, King of Prussia, PA and received funding in the form of salaries. Authors HC and YL are affiliated with Alliance Pharma, Malvern, PA and received funding in the form of salaries. The commercial affiliations for this work do not alter our adherence of PLOS ONE policies on sharing data and materials. The following patents assigned to GSK were filed on the CFI assay: US20160139118; US20170285024; WO2014203188A2; WO2014203188A3. There are no products in development or marketed products to declare.